NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

photonic5,

Thank you for sharing your thoughts with us here. Years ago I almost invested in VICL and their product Allovectin-7. One of the reasons I stayed out, other than early data that was not overly impressive, was that oncologists that were commenting about it were agreed that the product would fail to achieve approvable results. They were right. I believe you and the other doctors on this board are right about DCVax-L too. When doctors like you are seeing something they like with DCVax-L in spite of the fact regulators stopped this trial from screening more patients and then only allowed treatment patients into the trial from those already screened, then doctors are obviously not concerned by the halt. That's good for investors to know. Best wishes.